Adherence

Clinical Trial Utilizes DoseSmart Medication Adherence Platform and Smart Pill Bottle 7.23.18

Retrieved on: 
Monday, July 23, 2018
Health, Clinical pharmacology, Healthcare quality, Medical terminology, Adherence, Pharmacy, ClinicalTrials.gov, Clinical trial

SAN FRANCISCO, July 23, 2018 /PRNewswire-PRWeb/ --DoseSmart Inc. announced today that their proprietary medication adherence technology is currently being used in a new clinical trial (clinicaltrials.gov ID NCT03460587) which focuses on helping stroke survivors comply to their medication regime.

Key Points: 
  • SAN FRANCISCO, July 23, 2018 /PRNewswire-PRWeb/ --DoseSmart Inc. announced today that their proprietary medication adherence technology is currently being used in a new clinical trial (clinicaltrials.gov ID NCT03460587) which focuses on helping stroke survivors comply to their medication regime.
  • The trial will utilize the SmartBottle to record a daily dose of study-administered medication in simple format for efficient reporting to researchers in real time.
  • "DoseSmart developed a custom version of their software that adapted to our study needs and provides us with real time adherence data on each study medication dose.
  • The second part is the SmartBottle which stores, dispenses and tracks prescription medication and sends adherence data to the backend.

Medicine-On-Time Releases New Low Cost Medication Management Products

Retrieved on: 
Monday, July 23, 2018
Health, Clinical pharmacology, Medical terminology, Pharmacy, Healthcare quality, Patient safety, Adherence, Medication therapy management, Medical prescription, Adherence management coaching

TAMPA, Fla., July 23, 2018 /PRNewswire/ -- Medicine-On-Time, LLC (Medicine-On-Time) announced today the release of three new medication management products.

Key Points: 
  • TAMPA, Fla., July 23, 2018 /PRNewswire/ -- Medicine-On-Time, LLC (Medicine-On-Time) announced today the release of three new medication management products.
  • "Retail pharmacies who are beginning to offer medication synchronization and adherence packaging solutions need simple, cost effective products to enable these programs.
  • "The release of these new consumable products is further indication of Medicine-On-Time's commitment to strengthen its leadership position as the one true end-to-end medication management and adherence solution.
  • With more than 250 million prescriptions filled across the US, Medicine-On-Time is committed to improving patient quality of life through safe, accurate medication management solutions.

Omnicell to Release Second Quarter 2018 Earnings Results on July 26, 2018

Retrieved on: 
Thursday, July 19, 2018
Health, Medical terminology, Pharmacy, Healthcare quality, Adherence, Clinical pharmacology

MOUNTAIN VIEW, Calif., July 19, 2018 /PRNewswire/ --Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, July 26, 2018 to discuss the Company's Second Quarter 2018 financial results.

Key Points: 
  • MOUNTAIN VIEW, Calif., July 19, 2018 /PRNewswire/ --Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, July 26, 2018 to discuss the Company's Second Quarter 2018 financial results.
  • Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.
  • Available starting at 4:30 p.m. PT on July 26, 2018, through 11:59 p.m. PT on September 6, 2018.
  • Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care.

Wanda Expands Patient Management Platform with Enhanced Patient Adherence Features

Retrieved on: 
Wednesday, July 18, 2018
Health, Medical terminology, Healthcare quality, Pharmacy, Adherence, Clinical pharmacology, Health informatics

SAN FRANCISCO, July 18, 2018 /PRNewswire-PRWeb/ --Wanda, Inc. announces a significant expansion of their market-leading Patient Management Platform with expansive new features to further improve patient care plan adherence.

Key Points: 
  • SAN FRANCISCO, July 18, 2018 /PRNewswire-PRWeb/ --Wanda, Inc. announces a significant expansion of their market-leading Patient Management Platform with expansive new features to further improve patient care plan adherence.
  • The enhanced Patient Reminder Suite empowers clinicians to better engage patients in care plan adherence through personalized reminders and alerts, which can be pre-scheduled and delivered via multi-modal communications.
  • The enhancements also include the adoption of the Cloud Text-to-Speech API from Google that uses machine learning to deliver natural-sounding human voice automation.
  • The clinicians are able better deliver on their mission to provide great care with meaning and timely insight.

Geisinger and AstraZeneca Create New Asthma App Suite

Retrieved on: 
Tuesday, July 17, 2018
Medicine, Health, Asthma, Immune system, Immunology, Respiratory therapy, Respiratory diseases, Allergy, Adherence

Asthma symptoms can vary over time and worsening of asthma (an asthma attack) can be triggered by environmental exposure or allergies.

Key Points: 
  • Asthma symptoms can vary over time and worsening of asthma (an asthma attack) can be triggered by environmental exposure or allergies.
  • The new asthma app suite includes a mobile app that allows patients to view asthma-related weather forecasts, log symptoms and asthma triggers, establish medication reminders, track health status over time, and, crucially, communicate with their healthcare team.
  • Geisinger and AstraZeneca's partnership in developing the asthma app suite uses scientific expertise from both companies in disease management, patient engagement, adherence, healthcare innovation, research, and technology to fundamentally redesign how asthma patients are diagnosed and treated.
  • In 2017, the Geisinger Commonwealth School of Medicine and Geisinger Jersey Shore Hospital became the newest members of the Geisinger Family.

New Study Examines How to Generate the Support and Resources Needed to Sustain an Effective Patient Adherence Program

Retrieved on: 
Friday, July 6, 2018
Health, Healthcare quality, Medical terminology, Adherence, Clinical pharmacology, Pharmacy

It takes effective patient adherence program design and management to overcome these formidable hurdles.

Key Points: 
  • It takes effective patient adherence program design and management to overcome these formidable hurdles.
  • A new Best Practices, LLC study found that many pharma companies are segmenting patients and customizing content to enhance the results of their adherence programs.
  • Research and consulting leader Best Practices, LLC undertook this research to explore how adherence leaders in pharma are ensuring they have the support and resources to create effective patient adherence programs.
  • The study collected insights from 20 respondents in managerial or higher level positions at leading companies with patient adherence programs.

InventHelp Inventor Develops Prescription Medication Organizational System (NPL-204)

Retrieved on: 
Monday, June 25, 2018
Health, Pharmacy, Clinical pharmacology, Pharmacology, Pill organizer, Adherence, Draft:Pill Recognition

PITTSBURGH, June 25, 2018 /PRNewswire/ --An inventor from Fort Myers, Fla., has developed the patent-pending BEST PILL ORGANIZER, a system for dispensing oral medications.

Key Points: 
  • PITTSBURGH, June 25, 2018 /PRNewswire/ --An inventor from Fort Myers, Fla., has developed the patent-pending BEST PILL ORGANIZER, a system for dispensing oral medications.
  • "Individuals who require taking several medications throughout the day often have a difficult time keeping track of their medication schedule.
  • My improved pill organizer will solve these problems," said the inventor.
  • This system promotes better medication adherence, which will improve patient health outcomes.

Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients

Retrieved on: 
Saturday, June 23, 2018
Diabetes, Health, Medicine, Diabetes mellitus, Blood sugar level, Adherence, Diabetes management, Antidepressant

One study showed INVOKANA treatment resulted in similar blood glucose control while achieving greater treatment adherence, less therapy discontinuation and lower treatment cost, while a second study showed INVOKANA resulted in greater and longer-lasting weight loss.

Key Points: 
  • One study showed INVOKANA treatment resulted in similar blood glucose control while achieving greater treatment adherence, less therapy discontinuation and lower treatment cost, while a second study showed INVOKANA resulted in greater and longer-lasting weight loss.
  • "The findings of similar blood glucose control, greater adherence and lower treatment costs with INVOKANA are especially relevant for physicians and payers to consider for the treatment of type 2 diabetes."
  • With INVOKANA treatment, a significantly longer duration of clinically significant weight loss: 133 vs. 103 days, p=0.01.
  • However, they have limitations and cannot be used as stand-alone evidence to validate the efficacy and/or safety of a treatment.

Voluntis and Monarch Medical Technologies Announce Partnership to Provide Seamless Solution for Insulin Dosing Across the Continuum of Care

Retrieved on: 
Wednesday, June 20, 2018
Endocrine system, Medicine, Diabetes, Endocrinology, Eli Lilly and Company, Peptide hormones, Recombinant proteins, Insulin, RTT, Adherence, Basal, Diabetes mellitus type 2

Voluntis' Insulia is an FDA-cleared, prescription-only digital therapeutic for people and their care teams using basal insulin to treat type 2 diabetes.

Key Points: 
  • Voluntis' Insulia is an FDA-cleared, prescription-only digital therapeutic for people and their care teams using basal insulin to treat type 2 diabetes.
  • Insulia provides automated basal insulin dose recommendations and personalized coaching messages, while enabling the health care team to remotely monitor progress.
  • The partnership between the two companies supports adherence to insulin dosing regimens grounded in evidence-based standards of care throughout all care settings.
  • "We are proud to partner with Voluntis and provide a solution to support glycemic management across the continuum of care.

CenTrak Reports Significant Growth in Hand Hygiene Business and an Increase in Hospital Compliance Rates

Retrieved on: 
Friday, June 15, 2018
Health, Public health, Hygiene, Sanitation, Healthcare quality, Adherence, Clinical pharmacology, Medical terminology, Hand washing, Compliance

The solution leverages CenTrak's Internet of Things (IoT) offering to help healthcare organizations significantly improve hand hygiene adherence rates.

Key Points: 
  • The solution leverages CenTrak's Internet of Things (IoT) offering to help healthcare organizations significantly improve hand hygiene adherence rates.
  • One such deployment is in Denver Health Medical Center , a safety net hospital with 555 beds and 158-year history, which decided to bolster its existing hand hygiene improvement program with location-based Compliance Monitoring technology from CenTrak as a means to both affect and measure change in hand hygiene.
  • The technology provides objective measurements of hand hygiene adherence on its units, the ability to measure the adherence on all work shifts, and the ability to quantify the impact of certain interventions on hand hygiene compliance.
  • Denver Health's baseline hand hygiene compliance rates jumped from approximately 40 percent to a sustained rate of over 70 percent.